MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Colleagues,

As reported in Atlanta Business Journal...The University of Georgia landed a three-year $1.1 million U.S. Department of Defense grant to create a vaccine against glanders and melioidosis, pathogens that could be used as biological weapons. Bacteriologist Eric Lafontaine and immunologist Jeff Hogan, both in the UGA College of Veterinary Medicine, are co-principal investigators on the grant, which will test whether vaccination can protect mice in an aerosol (airborne) model of infection. Glanders and melioidosis are infectious diseases caused by bacteria of the genus Burkholderia.

Read on at: http://atlanta.bizjournals.com/atlanta/stories/2009/02/23/daily76.h...

ENJOY!

CC

Views: 3

© 2024   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service